Abstract

Diabetes mellitus (DM) has become an epidemic, causing a significant decline in quality of life of individuals due to its multisystem involvement. Kidney is an important target organ in DM accounting for the majority of patients requiring renal replacement therapy at dialysis units. Microalbuminuria (MA) has been a valuable tool to predict end-organ damage in DM but its low sensitivity has driven research efforts to seek other alternatives. Albumin is taken up by albumin receptors, megalin and cubilin in the proximal tubule epithelial cells. We demonstrated that insulin at physiological concentrations induce albumin endocytosis through activation of protein kinase B (Akt) in proximal tubule epithelial cells. Inhibition of Akt by a phosphorylation deficient construct abrogated insulin induced albumin endocytosis suggesting a role for Akt in insulin-induced albumin endocytosis. Furthermore we demonstrated a novel interaction between Akt substrate 160kDa (AS160) and cytoplasmic tail of megalin. Mice with type 1 DM (T1D) displayed decreased Akt, megalin, cubilin and AS160 expression in their kidneys in association with urinary cubilin shedding preceding significant MA. Patients with T1D who have developed MA in the EDC (The Pittsburgh Epidemiology of Diabetes Complications) study demonstrated urinary cubilin shedding prior to development of MA. We hypothesize that perturbed insulin-Akt cascade in DM leads to alterations in trafficking of megalin and cubilin, which results in urinary cubilin shedding as a prelude to MA in early diabetic nephropathy. We propose that utilization of urinary cubilin shedding, as a urinary biomarker, will allow us to detect and intervene in diabetic nephropathy (DN) at an earlier stage.

Highlights

  • Kidney is a major target organ in Diabetes mellitus (DM) accounting for forty five percent of new patients starting on renal replacement therapy [1]

  • We demonstrated a novel interaction between Akt substrate 160kDa (AS160) and cytoplasmic tail of megalin

  • Degree of albumin endocytosis was evaluated by fluorometric measurement of lysed Human kidney proximal tubule clone-8 (HKC-8) cells and the values are normalized for protein amount

Read more

Summary

Introduction

Kidney is a major target organ in DM accounting for forty five percent of new patients starting on renal replacement therapy [1]. An increase in prevalence of type 1 and type 2 DM by 21.1% and 30.5% respectively, was reported among children and adolescents in US between 2001–2009 [2]. Considering the future burden of the increased number of adults with DN, it is imperative to implement screening tools to detect early DN. Microalbuminuria is utilized as a clinical tool to monitor kidney damage and a predictive marker for future cardiovascular and neurocognitive complications [5, 6]. Previous reports of low sensitivity and advanced renal damage at the time of MA has prompted research efforts seeking alternative biomarkers to capture early molecular alterations in the kidney to predict development of DN [7,8,9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call